Back to search

France· FR:63759509

BIMATOPROST/TIMOLOL TEVA 0,3 mg/mL + 5 mg/mL, collyre en solution

A medicinal product containing maléate de timolol + bimatoprost, registered in France by TEVA SANTE, on the national reimbursement list.

Reimbursed in France (Assurance maladie)

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedBIMATOPROST/TIMOLOL TEVA 0,3 mg/mL + …ATC—REGISTER NO.FR:63759509PACKS LISTED1CHECKEDSeptember 12, 2026

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
MALÉATE DE TIMOLOL + BIMATOPROST
Manufacturer
TEVA SANTE
Country
France (FR)
ATC code
—
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400930107614
    1 flacon compte-gouttes polyéthylène basse densité (PEBD) avec fermeture de sécurité de 3 mL
    EUR 6.62

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Maléate de timolol + bimatoprost in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All maléate de timolol + bimatoprost products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

  • Austria · Bimatoprost/Timolol Genetic, Bimatoprost/Timolol Stada Arzneimittel Ag
  • Belgium · Duelym, Ganzed
  • Bulgaria · Бимасопт, Биматопрост Дуо
  • Cyprus · Birmost-Co, Duelym
  • Czechia · Bimatoprost/Timolol Olikla, Duelym
  • Germany · Bapiri, Bimatoprost / Timolol Biogaran
  • Denmark · Bimatoprost/Timolol Pharmathen, Bimatoprost/Timolol Stada
  • Estonia · Bimatoprost/Timolol Elvim, Bimatoprost/Timolol Teva
  • Spain · Bapiri, Bimatoprost/Timolol Stada
  • Finland · Bimatoprost/Timolol Stada, Bitifrin
  • United Kingdom (Northern Ireland) · Bimatoprost + Timolol Blumont Pharma, Bimatoprost/Timolol Aspire
  • Greece · Birmost-Co, Duelym
  • Croatia · Duelym
  • Ireland · Bitifrin, Duelym
  • Iceland · Bimatoprost/Timolol Stada, Duelym
  • Italy · Bimatoprost E Timololo Eg, Bimatoprost E Timololo Mylan
  • Liechtenstein · Ganfort
  • Lithuania · Bimatoprost/Timolol Elvim, Bimatoprost/Timolol Teva
  • Luxembourg · Duelym, Ganzed
  • Latvia · Bapiri, Bimatoprost/Timolol Elvim
  • Netherlands · Bimatoprost/Timolol Axunio, Bimatoprost/Timolol Blumont
  • Norway · Bimabloc, Bimtim
  • Poland · Bimaroz Duo, Bimifree Combi
  • Portugal · Eduelym, Ibrigan
  • Romania · Bimatoprost/Timolol Rompharm, Duelym
  • Sweden · Bimabloc, Bimatoprost/Timolol Brown & Burk
  • Slovakia · Bimatoprost/Timolol Olikla, Duelym

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/6948cb58-5a2e-435d-a94a-18e9196e8f3d
GET /v1/drugs/6948cb58-5a2e-435d-a94a-18e9196e8f3d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "63759509",
  "date_amm": "2017-07-17",
  "type_amm": "Procédure décentralisée",
  "numero_ue": null,
  "substance": "MALÉATE DE TIMOLOL + BIMATOPROST",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "collyre en solution",
  "voies_administration": "ophtalmique",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about maléate de timolol + bimatoprost.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.